Stay updated with breaking news from Clinical Development Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that LYBALVI® (olanzapine and samidorphan) is now available by prescription in the United States (U....
Tetra Bio-Pharma Inc. , a leader in cannabinoid-derived drug discovery and development today provided an update on the progress and significant achievements of its lead investigational drug,... | October 14, 2021
DGAP-News: Tetra Bio-Pharma Inc. / Key word(s): Miscellaneous Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF(TM) 14.10.2021 / 14:39 The issuer is solely responsible for the content of this announcement. Ottawa, October 14, 2021 (CNW) - Tetra Bio-Pharma Inc. (Tetra...
DGAP-News: Tetra Bio-Pharma Inc. / Key word(s): Miscellaneous Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF 14.10.2021 / 14:39 The issuer is solely
The International Vaccine Institute (IVI) and Bharat Biotech have started a Phase 2/3 clinical trial for a chikungunya vaccine candidate in Costa Rica.